Nebulized Lignocaine for Topical Airway Anesthesia During Flexible Bronchoscopy: A Randomized Controlled Trial
Launched by ALL INDIA INSTITUTE OF MEDICAL SCIENCES · Feb 1, 2017
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
For all patients meeting the inclusion criteria, the demographic profile including age, sex, weight, smoking history and the type of procedures performed during bronchoscopy shall be recorded. A written informed consent will be obtained from all participants. The patients who undergo flexible bronchoscopy would be randomised in a one is to one ratio either to nebulized lignocaine (4%) or saline (placebo) nebulization group. Prior to the bronchoscopy blood pressure, pulse rate, respiratory rate and pulse oximetry saturation will be recorded at the baseline Patients in both the groups shall b...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (Age \> 18 years) patients undergoing diagnostic or therapeutic flexible bronchoscopy
- Exclusion Criteria:
- • 1. Pregnancy
- • 2. Hypoxemia (oxygen saturation \[by pulse oximetry\] \< 92% with Fio2 of ≥ 0.3
- • 3. Bronchoscopy done through endotracheal or tracheostomy tube
- • 4. Not willing to provide informed consent.
- • 5. Patient requiring sedation for flexible bronchoscopy
- • 6. Patients with known allergy to lignocaine -
About All India Institute Of Medical Sciences
The All India Institute of Medical Sciences (AIIMS) is a premier medical institution and research center in India, recognized for its commitment to advancing healthcare through innovative research and clinical trials. Established with the mission to provide high-quality medical education, patient care, and groundbreaking research, AIIMS plays a pivotal role in the development and evaluation of new therapies and interventions. Its multidisciplinary approach, combined with a robust infrastructure and a team of leading healthcare professionals, positions AIIMS as a key player in the global clinical research landscape, dedicated to improving health outcomes and fostering scientific excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Delhi, , India
Patients applied
Trial Officials
Randeep Guleria, MD, DM
Study Chair
AIIMS, New Delhi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials